The U.S. Food and Drug Administration (FDA) is restricting the use of the Johnson & Johnson vaccine due to the risk of blood clots. The FDA is also investigating reports of viral relapses following the use of Pfizer’s COVID-19 pill.
The U.S. Food and Drug Administration (FDA) is restricting the use of the Johnson & Johnson vaccine due to the risk of blood clots. The FDA is also investigating reports of viral relapses following the use of Pfizer’s COVID-19 pill.